Patents Represented by Attorney, Agent or Law Firm Joseph K. Hemby
-
Patent number: 8287876Abstract: Recombinant chimeric antigens comprising unmodified and modified reactive polypeptide fragments of expressed product of the recombinant 56 kDa proteins of multiple strain of scrub typhus, such as Karp, Kato (Ktr56), Gilliam (Gmr56), and TA763 (TAr56). The invention is useful for detecting prior exposure to a number of strains of scrub typhus, based on the strength of reaction toward the chimeric protein and as a component in vaccine formulations and production of immune globulins for passive prophylaxis and immunity in subjects against heterologous infections.Type: GrantFiled: February 13, 2012Date of Patent: October 16, 2012Assignee: The United States of America as Represented by the Secretary of the NavyInventors: Wei-Mei Ching, Chien-Chung Chao
-
Patent number: 8241638Abstract: The invention relates to methods for the induction of an immune response to dengue virus. The method of inducing an immune response against dengue virus comprises administration of a non-replicating immunogen followed by a boost with a tetravalent live attenuated viral vaccine. Another aspect of the inventive subject matter is a method of inducing an immune response against dengue virus using a heterologous prime-boost regimen with the priming immunogen comprising a DNA expression system, an adenovirus expression vector or a Venezuelan equine encephalitis virus replicon system and the boosting immunogen comprising the same without the DNA expression system. Each expression system contains DNA sequences encoding dengue viral proteins.Type: GrantFiled: November 2, 2007Date of Patent: August 14, 2012Assignee: The United States of America as represented by the Secretary of the NavyInventors: Monika Simmons, Kevin R. Porter
-
Patent number: 8221764Abstract: The invention relates to an immunogenic composition composed of secreted polypeptides derived from Campylobacter jejuni non-flagellar proteins that are coordinately expressed with the flagellar regulon. The invention also relates to a method of inducing an immune response to the non-flagellar protein polypeptides.Type: GrantFiled: May 8, 2007Date of Patent: July 17, 2012Assignee: The United States of America as represented by the Secretary of the NavyInventors: Patricia Guerry-Kopecko, Shahida Baqar
-
Patent number: 8142787Abstract: Recombinant chimeric antigens comprising unmodified and modified reactive polypeptide fragments of expressed product of the recombinant 56 kDa proteins of multiple strain of scrub typhus, such as Karp, Kato (Ktr56), Gilliam (Gmr56), and TA763 (TAr56). The invention is useful for detecting prior exposure to a number of strains of scrub typhus, based on the strength of reaction toward the chimeric protein and as a component in vaccine formulations and production of immune globulins for passive prophylaxis and immunity in subjects against heterologous infections.Type: GrantFiled: May 10, 2011Date of Patent: March 27, 2012Assignee: The United States of America, as represented by the Secretary of the NavyInventors: Wei-Mei Ching, Chien-Chung Chao
-
Patent number: 8053487Abstract: This invention describes an adhesive used for bonding dental and medical biomaterials to hard tissues via a molecular bridge formed from calcium-reactive amines and acrylic or methacrylic ester monomers to hard tissues such as enamel, dentin, and bone. This formulation consists of an acid-stable polymerizable compound with multi-functional acrylate cross-linkers. This formula provides good self-adherence without prior preparation of the hard tissue substrates. The formulation can contain chemical- and/or light-activated free-radical initiators.Type: GrantFiled: January 30, 2009Date of Patent: November 8, 2011Assignee: The United States of America as represented by the Secretary of the NavyInventors: James C. Ragain, Jr., Amer Tiba, David G. Charlton
-
Patent number: 8029804Abstract: Recombinant chimeric antigens comprising unmodified and modified reactive polypeptide fragments of expressed product of the recombinant 56 kDa proteins of multiple strain of scrub typhus, such as Karp, Kato (Ktr56), Gilliam (Gmr56), and TA763 (TAr56). The invention is useful for detecting prior exposure to a number of strains of scrub typhus, based on the strength of reaction toward the chimeric protein and as a component in vaccine formulations and production of immune globulins for passive prophylaxis and immunity in subjects against heterologous infections.Type: GrantFiled: May 18, 2009Date of Patent: October 4, 2011Assignee: The United States of America as represented by the Secretary of the NavyInventors: Wei-Mei Ching, Chien-Chung Chao
-
Patent number: 7991165Abstract: An acoustic-electronic stethoscope that filters aberrant environmental background noise. The chest piece employs acoustic vents to inhibit resonant amplification of noise and contains a diaphragm design that focuses vibrational energy to a raised ring, which transfers and further focuses the energy to a piezoelectric polymer sensor with dual elements. The ensuing electrical signal is then preamplified with the low frequency sound, comprising predominantly background noise, filtered out. The stethoscope contains a binaural head set and output jack for down loading of data. Furthermore, areas normally subject to exposure and damage to water, such as the chest piece and headset, are water-tight.Type: GrantFiled: October 4, 2006Date of Patent: August 2, 2011Assignee: The United States of America as represented by the Secretary of the NavyInventors: James J. Kassal, Joseph S. Russotti
-
Patent number: 7933645Abstract: The invention relates to a method of determining early onset of motion sickness by brain imaging. The method discloses an objective means of determining the onset of motion sickness by evaluating a specific region of the brain. The method can also be utilized in evaluating the predisposition toward motion sickness in workers in occupations prone to motion sickness.Type: GrantFiled: March 30, 2006Date of Patent: April 26, 2011Assignee: The United States of America as represented by the Secretary of the NavyInventors: Chris Strychacz, Erik Viirre
-
Patent number: 7927595Abstract: Methods for modulating HIV-1 fusion cofactor expression by manipulating an accessory molecule on the surface of T cells, such as CD28, are described. The invention encompasses methods for modulating HIV-1 fusion cofactor expression by stimulating or inhibiting one or more intracellular signals which result from ligation of a surface receptor on a T cell which binds a costimulatory molecule. In one embodiment, expression of an HIV-1 fusion cofactor, such as CCR5, is downregulated by stimulating a CD28-associated signal in the T cell.Type: GrantFiled: February 20, 1998Date of Patent: April 19, 2011Assignee: The United States of America as represented by the Secretary of the NavyInventors: Carl H. June, Richard G. Carroll, James L. Riley, Daniel C. St. Louis, Bruce L. Levine
-
Patent number: 7928194Abstract: The invention relates to a recombinant immunogenic composition from Rickettsia typhi. The invention also relates to a method for the use of the recombinant proteins in detection and diagnostic assays and as a component in formulations for the induction of an anti-R. typhi immune response.Type: GrantFiled: July 27, 2007Date of Patent: April 19, 2011Assignee: The United States of America as represented by the Secretary of the NavyInventors: Wei-Mei Ching, Hua-Wei Chen
-
Patent number: 7897357Abstract: Here, we describe a sensitive and specific assay and kit for the detection of chemokines having activity that is upregulated by Th-1 cytokines (such IFN-?) and chemokines that upregulate the activity of Th-1 cytokines (such as IFN-?). In a typical embodiment, detection of the chemokine monokine induced by gamma interferon (MIG) provides a measure of the biological effect of IFN-? rather than direct quantitation of IFN-? or IFN-? secreting cells per se. Upregulation of MIG expression was observed following in vitro activation of PBMC with defined CD8+ T cell epitopes derived from influenza virus, CMV, or EBV, and in all cases this was antigen-specific, genetically restricted and dependent on both CD8+ T cells and IFN-?. Responses as assessed by the MIG assay paralleled those detected by conventional IFN-? ELISPOT, but the magnitude of response and sensitivity of the MIG assay were superior.Type: GrantFiled: October 18, 2001Date of Patent: March 1, 2011Assignee: The United States of America as represented by the Secretary of the NavyInventors: Gary Todd Brice, Denise L. Doolan, Stephen L. Hoffman
-
Patent number: 7846675Abstract: A recombinant, refolded non-fusion polypeptide expressed from a truncated r56 gene of the causative agent of scrub typhus, Orientia tsutsugamushi for the Karp, Kato and Gilliam strains has been produced. The invention is useful for detecting prior exposure to scrub typhus, screening for and/or identification of at least one infectious strain-similarity (i.e. a Karp-like, Kato-like or Gilliam-like strain) based on its strength of reaction toward a truncated protein and as a component in vaccine formulation sand production of immune globulins for passive prophylaxis and immunity in subjects.Type: GrantFiled: December 27, 2007Date of Patent: December 7, 2010Assignee: The United States of America as represented by the Secretary of the NavyInventors: Wei-Mei Ching, Daryl J. Kelly, Gregory A. Dasch
-
Patent number: 7824875Abstract: The invention relates to a method for the detection of prior exposure to Coxiella burnetii infection by antibody-based assays using recombinant, immunodominant C. burnetii polypeptides. The invention also relates to the design of biotin or His-tagged C. burnetii proteins useful in the antibody-based assays as standardized antigen reagents.Type: GrantFiled: December 11, 2007Date of Patent: November 2, 2010Assignee: The United States of America as represented by the Secretary of the NavyInventors: Wei-Mei Ching, Chien-Chung Chao, Xuan Li, Hua-Wei Chen
-
Patent number: 7824909Abstract: The invention relates to a method for the detection of prior exposure to Coxiella. burnetii infection by antibody-based assays using recombinant, immunodominant C. burnetii polypeptides. The invention also relates to the design of biotin or His-tagged C. burnetii proteins useful in the antibody-based assays as standardized antigen reagents.Type: GrantFiled: December 11, 2007Date of Patent: November 2, 2010Assignee: The United States of America as represented by the Secretary of the NavyInventors: Wei-Mei Ching, Chien-Chung Chao, Xuan Li, Hua-Wei Chen
-
Patent number: 7820395Abstract: A scrub typhus diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein is disclosed. Vaccines composed of r56 protein variants are also disclosed. Methods of reducing HIV viral loads using r47 and r56 proteins and antibodies raised against r47 and r56 are also disclosed.Type: GrantFiled: October 23, 2007Date of Patent: October 26, 2010Assignees: The United States of America as represented by the Secretary of the Navy, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.Inventors: Wei Mei Ching, Hong Ge, Chien-Chung Chao
-
Patent number: 7700578Abstract: An immunogenic composition, and method of using the composition to elicit an immune response to Campylobacter jejuni. The composition is an isolated polysaccharide polymer composed of one or more forms of disaccharide polymers.Type: GrantFiled: July 25, 2008Date of Patent: April 20, 2010Assignee: The United States of America as represented by the Secretary of the NavyInventors: Patricia Guerry, Mario Artur Monteiro
-
Patent number: 7699519Abstract: The invention relates to a method and apparatus to carry out the method for extracting petroleum distillate products from alcohol. The inventive method capitalizes on the discovered property that petroleum distillates, such as xylene and limonene, can be dissociated from their tight molecular interaction with alcohol by their higher affinity for water. The method also capitalizes on the discovered property that limonene, in the presence of water, forms terpin hydrate, forming particles that can be removed by filtration. Other, non-limonene petroleum distillates, once dissociated from alcohol, can be removed by distillation.Type: GrantFiled: September 11, 2006Date of Patent: April 20, 2010Assignee: The United States of America as represented by the Secretary of the NavyInventor: Mark H. Potts
-
Patent number: 7673746Abstract: The present invention is directed to a container for the collection and temporary storage of amalgams and other mercury wastes. The container can include a hollow body with air-tight lid, and one or more mercury sorbents contained in a filter bag. The filter bag covers the inside surface of the hollow body and has holes that allow air exchange between the air in the hollow body and the sorbents. As air exchange occurs, mercury vapors released from dental wastes binds to the mercury binding materials. A self-closing door was made on the lid, which automatically closes after each waste disposal.Type: GrantFiled: April 15, 2008Date of Patent: March 9, 2010Assignee: The United States of America as represented by the Secretary of the NavyInventors: Mark E. Stone, Ronald S. Karaway, Denise L. Berry
-
Patent number: 7649028Abstract: The invention relates to a temporary dental formulation useful as a durable, temporary restorative. The formulation changes color during mixing to assist the operator in ensuring adequacy of mixing and enhancing visualization during placement.Type: GrantFiled: January 24, 2007Date of Patent: January 19, 2010Assignee: The United States of America as represented by the Secretary of the NavyInventors: Amer Tiba, David G. Charlton, James C. Ragain
-
Patent number: 7638130Abstract: A recombinant, refolded non-fusion polypeptide expressed from a truncated r56 gene of the causative agent of scrub typhus, Orientia tsutsugamushi for the Karp, Kato and Gilliam strains has been produced. The invention is useful for detecting prior exposure to scrub typhus, screening for and/or identification of at least one infectious strain-similarity (i.e. a Karp-like, Kato-like or Gilliam-like strain) based on its strength of reaction toward a truncated protein and as a component in vaccine formulation sand production of immune globulins for passive prophylaxis and immunity in subjects.Type: GrantFiled: December 27, 2007Date of Patent: December 29, 2009Assignee: The United States of America as represented by the Secretary of the NavyInventors: Wei-Mei Ching, Daryl J. Kelly, Gregory A. Dasch